Elixxer Ltd. Announces Appointment of New Auditor
Elixxer Ltd. Announces Appointment of New Auditor
Montreal, Quebec--(Newsfile Corp. - April 17, 2023) - Elixxer Ltd. (TSXV: ELXR) ("Elixxer" or the "Company") is pleased to announce that Kreston GTA LLP ("Kreston") has been retained by the Company to be its auditor. Kreston takes over from Baker Tilly WM LLP ("Baker"), who resigned as the Company's auditor on their own initiative, as announced on October 28, 2022. The resignation of Baker and the appointment of Kreston have been reviewed by the Company's audit committee and the board of directors as a whole. Baker previously confirmed that there are no reportable events, "disagreements" or "unresolved issues" (as those terms are defined in National Instrument 51-102 - Continuous Disclosure Obligations) in connection with the change of auditor.
魁北克蒙特利爾--(Newsfile Corp.——2023 年 4 月 17 日)— Elixxer Ltd.(多倫多證券交易所股票代碼:ELXR)(”Elixxer“或者”公司“) 很高興地宣佈 Kreston GTA LLP (”克雷斯頓“)已被公司聘爲其審計師。克雷斯頓接任 Baker Tilly WM LLP (”貝克“),正如2022年10月28日宣佈的那樣,他主動辭去了公司審計師的職務。貝克的辭職和克雷斯頓的任命已經過公司審計委員會和整個董事會的審查。貝克此前證實,不存在應報告的事件、“分歧” 或 “未解決的問題”(如這些術語的定義所示) 國家儀器 51-102-持續披露義務)與更換審計師有關。
About Elixxer Ltd.
關於 Elixxer Ltd.
Elixxer is a Canadian public company listed on the TSX Venture Exchange (TSXV: ELXR) and the US OTC-Pink exchange (OTC Pink: ELIXF).
Elixxer是一家在多倫多證券交易所風險交易所(多倫多證券交易所股票代碼:ELXR)和美國OTC-Pink交易所(OTC Pink:ELIXF)上市的加拿大上市公司。
For further information please contact:
欲瞭解更多信息,請聯繫:
Ferras Zalt, Chairman and Interim CEO: +44 20 7409 6680; ferras@elixxer.com.
費拉斯·扎爾特,董事長兼臨時首席執行官:+44 20 7409 6680;ferras@elixxer.com。
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
多倫多證券交易所風險投資交易所及其監管服務提供商(該術語在多倫多證券交易所風險投資交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。
Notice Regarding Forward-Looking Statements
關於前瞻性陳述的通知
This press release may contain forward-looking statements with respect to Elixxer and its operations, strategy, investments, financial performance and condition. These statements can generally be identified by use of forward-looking words such as "may", "will", "expect", "estimate", "anticipate", "intends", "believe" or "continue" or the negative thereof or similar variations. The actual results and performance of Elixxer could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under "Risk Factors and Risk Management" in Elixxer's most recent Management's Discussion and Analysis filed on SEDAR (). The cautionary statements qualify all forward-looking statements attributable to Elixxer and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release, and Elixxer has no obligation to update such statements, except to the extent required by applicable securities laws.
本新聞稿可能包含有關Elixxer及其運營、戰略、投資、財務業績和狀況的前瞻性陳述。這些陳述通常可以通過使用前瞻性詞語來識別,例如 “可能”、“將”、“期望”、“估計”、“預期”、“打算”、“相信” 或 “繼續”,或者其否定詞或類似變體。Elixxer的實際業績和表現可能與此類陳述所表達或暗示的結果存在重大差異。此類陳述完全受圍繞未來預期的固有風險和不確定性的限制。一些可能導致實際業績與預期存在重大差異的重要因素包括一般經濟和市場因素、競爭、政府監管以及Elixxer在SEDAR上提交的最新管理層討論與分析中 “風險因素與風險管理” 中描述的因素()。警示性陳述符合所有歸因於Elixxer及其代表的人員的前瞻性陳述。除非另有說明,否則所有前瞻性陳述僅代表截至本新聞稿發佈之日,除非適用的證券法要求,否則Elixxer沒有義務更新此類陳述。
To view the source version of this press release, please visit
要查看本新聞稿的源版本,請訪問